DaVita HealthCare Partners Stock Price, News & Analysis (NYSE:DVA)

$57.15 1.76 (3.18 %)
(As of 11/24/2017 04:49 AM ET)
Previous Close$55.39
Today's Range$56.08 - $57.23
52-Week Range$52.51 - $70.16
Volume1.95 million shs
Average Volume1.96 million shs
Market Capitalization$10.48 billion
P/E Ratio15.83
Dividend YieldN/A
Beta0.98

About DaVita HealthCare Partners (NYSE:DVA)

DaVita HealthCare Partners logoDaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

Receive DVA News and Ratings via Email

Sign-up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Healthcare Facilities & Services
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:DVA
CUSIP23918K10
Phone303-405-2100

Debt

Debt-to-Equity Ratio1.79%
Current Ratio1.40%
Quick Ratio1.35%

Price-To-Earnings

Trailing P/E Ratio15.83
Forward P/E Ratio16.71
P/E Growth11.17

Sales & Book Value

Annual Sales$14.75 billion
Price / Sales0.73
Cash Flow$7.75 per share
Price / Cash7.37
Book Value$26.26 per share
Price / Book2.18

Profitability

Trailing EPS$2.60
Net Income$879.87 million
Net Margins3.40%
Return on Equity13.31%
Return on Assets3.55%

Miscellaneous

Employees70,300
Outstanding Shares189,230,000

Frequently Asked Questions for DaVita HealthCare Partners (NYSE:DVA)

What is DaVita HealthCare Partners' stock symbol?

DaVita HealthCare Partners trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

How will DaVita HealthCare Partners' stock buyback program work?

DaVita HealthCare Partners announced that its board has authorized a stock buyback plan on Wednesday, October 11th 2017, which permits the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company's board believes its shares are undervalued.

How were DaVita HealthCare Partners' earnings last quarter?

DaVita HealthCare Partners Inc. (NYSE:DVA) issued its quarterly earnings data on Tuesday, November, 7th. The company reported $0.81 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.94 by $0.13. The company earned $3.92 billion during the quarter, compared to the consensus estimate of $3.91 billion. DaVita HealthCare Partners had a net margin of 3.40% and a return on equity of 13.31%. DaVita HealthCare Partners's revenue was up 5.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.95 EPS. View DaVita HealthCare Partners' Earnings History.

When will DaVita HealthCare Partners make its next earnings announcement?

DaVita HealthCare Partners is scheduled to release their next quarterly earnings announcement on Wednesday, February, 14th 2018. View Earnings Estimates for DaVita HealthCare Partners.

Where is DaVita HealthCare Partners' stock going? Where will DaVita HealthCare Partners' stock price be in 2017?

9 equities research analysts have issued twelve-month price targets for DaVita HealthCare Partners' stock. Their forecasts range from $57.00 to $70.00. On average, they anticipate DaVita HealthCare Partners' stock price to reach $63.00 in the next twelve months. View Analyst Ratings for DaVita HealthCare Partners.

Who are some of DaVita HealthCare Partners' key competitors?

Who are DaVita HealthCare Partners' key executives?

DaVita HealthCare Partners' management team includes the folowing people:

  • Kent J. Thiry, Chairman of the Board (Age 61)
  • James K. Hilger, Interim Chief Financial Officer, Chief Accounting Officer (Age 55)
  • Joel Ackerman, Chief Financial Officer (Age 51)
  • Robert Lang, President, International Business
  • Javier J. Rodriguez, Chief Executive Officer - Kidney Care (Age 46)
  • Jeanine M. Jiganti, Chief Compliance Officer (Age 57)
  • LeAnne M. Zumwalt, Group Vice President - purchasing and government affairs (Age 58)
  • Michael D. Staffieri, Chief Operating Officer- Kidney Care (Age 42)
  • Kathleen Alyce Waters, Chief Legal Officer (Age 49)
  • Peter T. Grauer, Lead Director, Independent Director (Age 71)

Who owns DaVita HealthCare Partners stock?

DaVita HealthCare Partners' stock is owned by many different of retail and institutional investors. Top institutional shareholders include California Public Employees Retirement System (0.26%), Canada Pension Plan Investment Board (0.23%), Schroder Investment Management Group (0.23%), Speece Thorson Capital Group Inc. (0.17%), Rhumbline Advisers (0.17%) and Hikari Power Ltd (0.16%). Company insiders that own DaVita HealthCare Partners stock include Charles Berg, Christopher James Schnarr, Dennis Kogod, James K Hilger, Javier Rodriguez, Jeanine Marie Jiganti, John M Nehra, Kent J Thiry, Laura Mildenberger, Leanne M Zumwalt, Michael David Staffieri, Pamela M Arway, Roger Valine and William L Roper. View Institutional Ownership Trends for DaVita HealthCare Partners.

Who sold DaVita HealthCare Partners stock? Who is selling DaVita HealthCare Partners stock?

DaVita HealthCare Partners' stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Aperio Group LLC, Public Employees Retirement Association of Colorado, SG Americas Securities LLC and Whittier Trust Co.. Company insiders that have sold DaVita HealthCare Partners company stock in the last year include Charles Berg, Javier Rodriguez and William L Roper. View Insider Buying and Selling for DaVita HealthCare Partners.

Who bought DaVita HealthCare Partners stock? Who is buying DaVita HealthCare Partners stock?

DaVita HealthCare Partners' stock was purchased by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Canada Pension Plan Investment Board, Speece Thorson Capital Group Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Hikari Power Ltd, Accident Compensation Corp, Rhumbline Advisers and FDx Advisors Inc.. View Insider Buying and Selling for DaVita HealthCare Partners.

How do I buy DaVita HealthCare Partners stock?

Shares of DaVita HealthCare Partners can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DaVita HealthCare Partners' stock price today?

One share of DaVita HealthCare Partners stock can currently be purchased for approximately $57.15.

How big of a company is DaVita HealthCare Partners?

DaVita HealthCare Partners has a market capitalization of $10.48 billion and generates $14.75 billion in revenue each year. The company earns $879.87 million in net income (profit) each year or $2.60 on an earnings per share basis. DaVita HealthCare Partners employs 70,300 workers across the globe.

How can I contact DaVita HealthCare Partners?

DaVita HealthCare Partners' mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 303-405-2100 or via email at [email protected]


MarketBeat Community Rating for DaVita HealthCare Partners (DVA)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  288 (Vote Outperform)
Underperform Votes:  308 (Vote Underperform)
Total Votes:  596
MarketBeat's community ratings are surveys of what our community members think about DaVita HealthCare Partners and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for DaVita HealthCare Partners (NYSE:DVA)

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 1.801.801.872.27
Ratings Breakdown: 4 Sell Rating(s)
8 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
4 Sell Rating(s)
8 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
11 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
9 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $66.56$67.89$69.73$71.00
Price Target Upside: 21.03% upside14.39% upside20.84% upside9.65% upside

Consensus Price Target History for DaVita HealthCare Partners (NYSE:DVA)

Price Target History for DaVita HealthCare Partners (NYSE:DVA)

Analysts' Ratings History for DaVita HealthCare Partners (NYSE:DVA)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/13/2017KeyCorpReiterated RatingHoldN/AView Rating Details
11/10/2017Robert W. BairdReiterated RatingHold$63.00N/AView Rating Details
11/8/2017Bank of America CorporationLower Price TargetNeutral$75.00 -> $66.00N/AView Rating Details
11/8/2017Royal Bank Of CanadaLower Price TargetSector Perform$64.00 -> $60.00N/AView Rating Details
10/23/2017Wolfe ResearchUpgradeMarket Perform -> OutperformN/AView Rating Details
10/15/2017SunTrust Banks, Inc.Set Price TargetHold$57.00N/AView Rating Details
10/9/2017J P Morgan Chase & CoDowngradeNeutral -> UnderweightN/AView Rating Details
8/3/2017Jefferies Group LLCReiterated RatingHold$70.00MediumView Rating Details
5/25/2017Goldman Sachs Group IncReiterated RatingSell$62.00HighView Rating Details
11/1/2016Wells Fargo & CompanyReiterated RatingOutperformN/AView Rating Details
9/20/2016Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$75.00N/AView Rating Details
9/6/2016Citigroup Inc.Initiated CoverageNeutral$71.00N/AView Rating Details
4/6/2016Susquehanna Bancshares IncBoost Price TargetNeutral$70.00 -> $78.00N/AView Rating Details
3/2/2016Sanford C. BernsteinLower Price TargetMarket Perform$74.50 -> $71.00N/AView Rating Details
2/12/2016William BlairReiterated RatingBuyN/AView Rating Details
2/12/2016Piper Jaffray CompaniesReiterated RatingOverweight$90.00 -> $85.00N/AView Rating Details
(Data available from 11/25/2015 forward)

Earnings

Earnings History and Estimates Chart for DaVita HealthCare Partners (NYSE:DVA)

Earnings by Quarter for DaVita HealthCare Partners (NYSE:DVA)

Earnings History by Quarter for DaVita HealthCare Partners (NYSE DVA)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/14/2018$0.92N/AView Earnings Details
11/7/2017Q3 2017$0.94$0.81$3.91 billion$3.92 billionViewN/AView Earnings Details
8/1/2017Q2 2017$0.90$0.92$3.82 billion$3.88 billionViewListenView Earnings Details
5/2/2017Q1 2017$0.82$0.79$3.69 billion$3.70 billionViewListenView Earnings Details
2/16/2017Q4 2016$0.91$0.98$3.74 billion$3.72 billionViewListenView Earnings Details
11/2/2016Q316$0.94$0.95$3.72 billion$3.73 billionViewListenView Earnings Details
8/8/2016Q216$0.98$1.01$3.67 billion$3.72 billionViewListenView Earnings Details
5/4/2016Q116$0.86$0.92$3.51 billion$3.58 billionViewListenView Earnings Details
2/11/2016Q415$0.97$1.01$3.50 billion$3.53 billionViewListenView Earnings Details
11/3/2015Q315$0.97$1.00$3.46 billion$3.53 billionViewListenView Earnings Details
8/4/2015Q215$0.95$0.95$3.37 billion$3.43 billionViewListenView Earnings Details
5/4/2015Q115$0.86$0.86$3.25 billion$3.29 billionViewListenView Earnings Details
2/12/2015Q414$0.89$0.96$3.26 billion$3.33 billionViewListenView Earnings Details
11/6/2014Q314$0.91$0.90$3.19 billion$3.25 billionViewListenView Earnings Details
7/31/2014Q214$0.88$0.95$3.10 billion$3.17 billionViewListenView Earnings Details
5/1/2014Q1$0.87$0.85$3.02 billion$3.04 billionViewListenView Earnings Details
2/11/2014Q413$1.91$0.99$2.92 billion$3.06 billionViewListenView Earnings Details
11/5/2013Q313$0.96$0.98$2.93 billion$3.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$1.84$1.84$2.88 billion$2.87 billionViewListenView Earnings Details
5/7/2013Q1 2013$1.80$1.84$2.78 billion$2.83 billionViewListenView Earnings Details
2/14/2013Q4 2012$1.60$1.85$2.40 billion$2.48 billionViewListenView Earnings Details
10/30/2012$1.55$1.56ViewN/AView Earnings Details
8/1/2012$1.47$1.49ViewN/AView Earnings Details
2/16/2012$1.49$1.58ViewN/AView Earnings Details
11/3/2011$1.46$1.45ViewN/AView Earnings Details
8/3/2011$1.14$1.17ViewN/AView Earnings Details
5/2/2011$0.95$0.96ViewN/AView Earnings Details
2/10/2011$1.12$0.70ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for DaVita HealthCare Partners (NYSE:DVA)
2017 EPS Consensus Estimate: $3.54
2018 EPS Consensus Estimate: $3.59
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.77$0.84$0.81
Q2 20173$0.90$0.92$0.91
Q3 20173$0.90$0.95$0.93
Q4 20173$0.89$0.90$0.89
Q1 20182$0.77$0.80$0.79
Q2 20182$0.94$0.94$0.94
Q3 20182$0.95$0.95$0.95
Q4 20182$0.90$0.92$0.91
Q1 20191$0.85$0.85$0.85
Q2 20191$1.05$1.05$1.05
Q3 20191$1.04$1.04$1.04
(Data provided by Zacks Investment Research)

Dividends

Dividend History for DaVita HealthCare Partners (NYSE:DVA)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for DaVita HealthCare Partners (NYSE DVA)

Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 86.37%
Insider Trades by Quarter for DaVita HealthCare Partners (NYSE:DVA)
Institutional Ownership by Quarter for DaVita HealthCare Partners (NYSE:DVA)

Insider Trades by Quarter for DaVita HealthCare Partners (NYSE DVA)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2017Javier RodriguezCEOSell1,294$66.21$85,675.74View SEC Filing  
5/9/2017Charles BergDirectorSell8,414$65.80$553,641.20View SEC Filing  
5/4/2017William L RoperDirectorSell12,994$65.89$856,174.66View SEC Filing  
8/9/2016Michael David StaffieriCOOSell20,262$73.09$1,480,949.58View SEC Filing  
7/11/2016Jeanine Marie JigantiInsiderSell1,291$78.51$101,356.41View SEC Filing  
7/1/2016Jeanine Marie JigantiInsiderSell4,620$77.45$357,819.00View SEC Filing  
5/25/2016Pamela M ArwayDirectorSell10,824$77.16$835,179.84View SEC Filing  
5/23/2016James K HilgerCFOSell3,416$76.79$262,314.64View SEC Filing  
5/20/2016Kent J ThiryCEOSell32,880$76.99$2,531,431.20View SEC Filing  
5/17/2016Dennis KogodCEOSell17,700$77.35$1,369,095.00View SEC Filing  
5/17/2016Leanne M ZumwaltVPSell538$77.08$41,469.04View SEC Filing  
5/16/2016James K HilgerCFOSell3,983$75.59$301,074.97View SEC Filing  
5/16/2016Javier RodriguezCEOSell36,466$75.44$2,750,995.04View SEC Filing  
5/16/2016Michael David StaffieriCOOSell4,934$75.69$373,454.46View SEC Filing  
5/12/2016Roger ValineDirectorSell8,220$76.34$627,514.80View SEC Filing  
5/10/2016Dennis KogodCEOSell40,048$76.25$3,053,660.00View SEC Filing  
5/6/2016John M NehraDirectorSell16,314$75.56$1,232,685.84View SEC Filing  
4/11/2016Javier RodriguezCEOSell89,912$73.51$6,609,431.12View SEC Filing  
3/21/2016Dennis KogodCEOSell13,455$72.12$970,374.60View SEC Filing  
2/29/2016Pamela M ArwayDirectorSell9,026$66.00$595,716.00View SEC Filing  
2/23/2016Leanne M. ZumwaltVPSell14,587$64.25$937,214.75View SEC Filing  
2/16/2016Dennis KogodCEOSell33,290$61.99$2,063,647.10View SEC Filing  
1/13/2016Christopher James SchnarrInsiderBuy5,000$0.68$3,400.00
1/11/2016Christopher James SchnarrInsiderBuy10,000$0.60$6,000.00
12/17/2015Laura MildenbergerinsiderSell1,440$68.14$98,121.60View SEC Filing  
9/22/2015Kim M. RiverainsiderSell40,037$75.48$3,021,992.76View SEC Filing  
8/17/2015Carol Anthony DavidsonDirectorSell4,038$79.93$322,757.34View SEC Filing  
6/4/2015Robert J MargolisChairmanSell31,400$83.39$2,618,446.00View SEC Filing  
5/28/2015Michael David StaffieriCOOSell9,050$84.07$760,833.50View SEC Filing  
5/19/2015Robert J MargolisChairmanSell15,700$83.22$1,306,554.00View SEC Filing  
5/18/2015James K HilgerCFOSell3,983$82.10$327,004.30View SEC Filing  
5/18/2015Michael David StaffieriCOOSell2,047$82.03$167,915.41View SEC Filing  
5/18/2015Robert J MargolisChairmanSell15,700$82.24$1,291,168.00View SEC Filing  
5/11/2015James K HilgerCFOSell8,267$82.00$677,894.00View SEC Filing  
5/11/2015Jeanine Marie JigantiInsiderSell2,481$81.95$203,317.95View SEC Filing  
5/11/2015John M NehraDirectorSell12,278$81.85$1,004,954.30View SEC Filing  
4/21/2015Robert J MargolisChairmanSell31,400$82.40$2,587,360.00View SEC Filing  
4/7/2015Robert J MargolisChairmanSell15,700$82.15$1,289,755.00View SEC Filing  
4/6/2015Robert J MargolisChairmanSell15,700$81.49$1,279,393.00View SEC Filing  
3/27/2015Robert J MargolisChairmanSell31,400$81.18$2,549,052.00View SEC Filing  
3/12/2015Robert J MargolisChairmanSell107,374$79.24$8,508,315.76View SEC Filing  
2/27/2015Robert J MargolisChairmanSell21,000$74.29$1,560,090.00View SEC Filing  
2/19/2015Robert J MargolisChairmanSell21,000$73.12$1,535,520.00View SEC Filing  
1/30/2015Robert J MargolisChairmanSell31,400$75.48$2,370,072.00View SEC Filing  
1/23/2015Michael David StaffieriCOOSell21,869$76.05$1,663,137.45View SEC Filing  
1/16/2015Robert J MargolisChairmanSell31,400$74.92$2,352,488.00View SEC Filing  
1/8/2015Kim M RiveraInsiderSell1,111$75.10$83,436.10View SEC Filing  
12/30/2014Robert J MargolisChairmanSell31,400$76.09$2,389,226.00View SEC Filing  
12/29/2014Robert J MargolisChairmanSell15,700$76.09$1,194,613.00View SEC Filing  
12/19/2014Laura MildenbergerInsiderSell1,446$75.50$109,173.00View SEC Filing  
12/18/2014Robert J MargolisChairmanSell31,400$74.67$2,344,638.00View SEC Filing  
12/3/2014Robert J MargolisChairmanSell31,400$75.80$2,380,120.00View SEC Filing  
12/1/2014Kim M RiveraInsiderSell6,503$76.08$494,748.24View SEC Filing  
11/21/2014Robert J MargolisChairmanSell31,400$75.08$2,357,512.00View SEC Filing  
11/11/2014Kent J ThiryCEOSell344,938$74.52$25,704,779.76View SEC Filing  
11/11/2014Robert J MargolisChairmanSell250,000$75.09$18,772,500.00View SEC Filing  
11/10/2014Berkshire Hathaway IncMajor ShareholderBuy944,418$74.11$69,990,817.98View SEC Filing  
11/7/2014R. Ted WeschlerMajor ShareholderBuy820,018$74.10$60,763,333.80View SEC Filing  
11/3/2014Roger ValineDirectorSell7,185$77.85$559,352.25View SEC Filing  
9/16/2014John M NehraDirectorSell20,000$73.91$1,478,200.00View SEC Filing  
9/8/2014Kim M RiveraInsiderSell1,111$74.25$82,491.75View SEC Filing  
8/27/2014Leanne M ZumwaltVPSell3,214$74.57$239,667.98View SEC Filing  
8/11/2014Jeanine Marie JigantiInsiderSell2,500$72.14$180,350.00View SEC Filing  
6/11/2014Kim M RiveraInsiderSell5,929$71.05$421,255.45View SEC Filing  
5/29/2014Laura MildenbergerInsiderSell5,080$69.99$355,549.20View SEC Filing  
5/16/2014Dennis KogodCOOSell18,750$67.30$1,261,875.00View SEC Filing  
5/16/2014Kent ThiryCEOSell17,600$67.41$1,186,416.00View SEC Filing  
5/15/2014James HilgerCAOSell1,666$67.23$112,005.18View SEC Filing  
5/15/2014Javier RodriguezCEOSell7,000$67.50$472,500.00View SEC Filing  
5/12/2014Dennis KogodCOOSell32,188$68.06$2,190,715.28View SEC Filing  
5/8/2014Dennis KogodCOOSell32,213$67.36$2,169,867.68View SEC Filing  
5/7/2014Michael David StaffieriCOOSell2,633$67.30$177,200.90View SEC Filing  
4/2/2014Michael David StaffieriCOOSell2,867$69.15$198,253.05View SEC Filing  
3/20/2014Laura MildenbergerInsiderSell3,274$70.04$229,310.96View SEC Filing  
2/26/2014R. Ted Weschlermajor shareholderBuy1,159,858$66.97$77,675,690.26View SEC Filing  
2/21/2014John NehraDirectorSell40,000$65.81$2,632,400.00View SEC Filing  
2/18/2014William RoperDirectorSell42,519$66.37$2,821,986.03View SEC Filing  
12/20/2013Laura MildenbergerInsiderSell10,417$62.53$651,375.01View SEC Filing  
12/17/2013Allen NissensonInsiderSell2,929$59.83$175,242.07View SEC Filing  
12/9/2013Berkshire Hathaway Incmajor shareholderBuy1,314,170$57.84$76,011,592.80View SEC Filing  
11/8/2013R. Ted Weschlermajor shareholderBuy3,700,294$55.14$204,034,211.16View SEC Filing  
7/5/2013Berkshire Hathaway IncMajor ShareholderBuy110,309$114.01$12,576,329.09View SEC Filing  
7/3/2013R. Ted WeschlerMajor ShareholderBuy639,200$114.78$73,367,376.00View SEC Filing  
5/15/2013David T ShapiroInsiderSell8,779$129.80$1,139,514.20View SEC Filing  
5/15/2013Dennis KogodCOOSell21,130$129.47$2,735,701.10View SEC Filing  
5/15/2013James K HilgerCFOSell1,049$130.18$136,558.82View SEC Filing  
5/15/2013Leanne M ZumwaltVPSell13,209$129.59$1,711,754.31View SEC Filing  
5/13/2013Kent J ThiryCEOSell243,307$129.95$31,617,744.65View SEC Filing  
5/13/2013Kim M RiveraInsiderSell1,672$129.70$216,858.40View SEC Filing  
3/4/2013Berkshire Hathaway IncMajor ShareholderBuy164,947$119.59$19,726,011.73View SEC Filing  
3/4/2013Roger ValineDirectorSell1,390$120.00$166,800.00View SEC Filing  
2/27/2013Berkshire Hathaway IncMajor ShareholderBuy211,889$116.56$24,697,781.84View SEC Filing  
2/22/2013Berkshire Hathaway IncMajor ShareholderBuy224,091$115.88$25,967,665.08View SEC Filing  
2/19/2013Berkshire Hathaway IncMajor ShareholderBuy323,070$116.73$37,711,961.10View SEC Filing  
2/5/2013Berkshire Hathaway IncMajor ShareholderBuy32,376$115.17$3,728,743.92View SEC Filing  
2/4/2013Roger ValineDirectorSell1,389$116.13$161,304.57View SEC Filing  
1/16/2013Berkshire Hathaway IncMajor ShareholderBuy42,400$111.33$4,720,392.00View SEC Filing  
1/15/2013Berkshire Hathaway IncMajor ShareholderBuy179,300$109.67$19,663,831.00View SEC Filing  
1/10/2013Berkshire Hathaway IncMajor ShareholderBuy187,898$109.54$20,582,346.92View SEC Filing  
12/24/2012Dennis KogodCOOSell12,736$111.00$1,413,696.00View SEC Filing  
12/21/2012James K HilgerCFOSell2,073$112.20$232,590.60View SEC Filing  
12/6/2012Berkshire Hathaway IncMajor ShareholderBuy635,633$106.20$67,504,224.60View SEC Filing  
11/29/2012Berkshire Hathaway IncMajor ShareholderBuy679,249$108.20$73,494,741.80View SEC Filing  
11/26/2012Berkshire Hathaway IncMajor ShareholderBuy412,050$110.38$45,482,079.00View SEC Filing  
11/16/2012Berkshire Hathaway IncMajor ShareholderBuy132,958$112.45$14,951,127.10View SEC Filing  
11/12/2012Berkshire Hathaway IncMajor ShareholderBuy548,823$112.15$61,550,499.45View SEC Filing  
11/7/2012Berkshire Hathaway IncMajor ShareholderBuy139,491$112.03$15,627,176.73View SEC Filing  
11/2/2012Berkshire Hathaway IncMajor ShareholderBuy254,750$112.20$28,582,950.00View SEC Filing  
10/26/2012Berkshire Hathaway IncMajor ShareholderBuy257,941$111.14$28,667,562.74View SEC Filing  
10/17/2012Berkshire Hathaway IncMajor ShareholderBuy63,928$109.56$7,003,951.68View SEC Filing  
10/12/2012Berkshire Hathaway IncMajor ShareholderBuy217,597$109.76$23,883,446.72View SEC Filing  
10/9/2012Berkshire Hathaway IncMajor ShareholderBuy67,946$107.71$7,318,463.66View SEC Filing  
9/28/2012Berkshire Hathaway IncMajor ShareholderBuy282,403$102.03$28,813,578.09View SEC Filing  
8/8/2012Kent J ThiryChairmanSell320,877$96.88$31,086,563.76View SEC Filing  
8/7/2012William L RoperDirectorSell23,019$95.95$2,208,673.05View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for DaVita HealthCare Partners (NYSE DVA)

Source:
DateHeadline
The Hot Stock: DaVita Climbs 3.2%The Hot Stock: DaVita Climbs 3.2%
finance.yahoo.com - November 24 at 4:13 PM
DaVita IncDaVita Inc
www.bloomberg.com - November 24 at 10:49 AM
Exclusive: DaVita explores sale of physician network business - sourcesExclusive: DaVita explores sale of physician network business - sources
finance.yahoo.com - November 22 at 6:50 PM
DaVita Issues Downbeat 17 View, Hurricanes Affect Q3 Results - NasdaqDaVita Issues Downbeat '17 View, Hurricanes Affect Q3 Results - Nasdaq
www.nasdaq.com - November 16 at 1:39 PM
DaVita Issues Downbeat '17 View, Hurricanes Affect Q3 ResultsDaVita Issues Downbeat '17 View, Hurricanes Affect Q3 Results
finance.yahoo.com - November 16 at 1:39 PM
DaVita HealthCare Partners Inc. Expected to Earn FY2017 Earnings of $3.42 Per Share (DVA)DaVita HealthCare Partners Inc. Expected to Earn FY2017 Earnings of $3.42 Per Share (DVA)
www.americanbankingnews.com - November 14 at 8:44 AM
Contrasting Fresenius Medical Care Corporation (FMS) & DaVita HealthCare Partners (DVA)Contrasting Fresenius Medical Care Corporation (FMS) & DaVita HealthCare Partners (DVA)
www.americanbankingnews.com - November 13 at 11:28 AM
DaVita HealthCare Partners Inc. (DVA) Receives Consensus Recommendation of "Hold" from AnalystsDaVita HealthCare Partners Inc. (DVA) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 13 at 2:56 AM
DaVita HealthCare Partners Inc. (DVA) Given "Hold" Rating at Robert W. BairdDaVita HealthCare Partners Inc. (DVA) Given "Hold" Rating at Robert W. Baird
www.americanbankingnews.com - November 11 at 11:12 AM
Zacks: Analysts Anticipate DaVita HealthCare Partners Inc. (DVA) Will Announce Quarterly Sales of $3.89 BillionZacks: Analysts Anticipate DaVita HealthCare Partners Inc. (DVA) Will Announce Quarterly Sales of $3.89 Billion
www.americanbankingnews.com - November 11 at 10:22 AM
DaVita, Inc. – Value Analysis (NYSE:DVA) : November 10, 2017DaVita, Inc. – Value Analysis (NYSE:DVA) : November 10, 2017
finance.yahoo.com - November 10 at 6:35 PM
DaVita Honors and Supports VeteransDaVita Honors and Supports Veterans
finance.yahoo.com - November 10 at 11:09 AM
DaVita, Inc. breached its 50 day moving average in a Bearish Manner : DVA-US : November 9, 2017DaVita, Inc. breached its 50 day moving average in a Bearish Manner : DVA-US : November 9, 2017
finance.yahoo.com - November 10 at 11:09 AM
New Strong Sell Stocks for November 10thNew Strong Sell Stocks for November 10th
finance.yahoo.com - November 10 at 11:09 AM
DaVita HealthCare Partners Inc. to Post FY2017 Earnings of $3.43 Per Share, SunTrust Banks Forecasts (DVA)DaVita HealthCare Partners Inc. to Post FY2017 Earnings of $3.43 Per Share, SunTrust Banks Forecasts (DVA)
www.americanbankingnews.com - November 9 at 7:54 AM
DaVita HealthCare Partners Inc. Forecasted to Earn FY2017 Earnings of $3.40 Per Share (DVA)DaVita HealthCare Partners Inc. Forecasted to Earn FY2017 Earnings of $3.40 Per Share (DVA)
www.americanbankingnews.com - November 9 at 7:54 AM
Edited Transcript of DVA earnings conference call or presentation 7-Nov-17 10:00pm GMTEdited Transcript of DVA earnings conference call or presentation 7-Nov-17 10:00pm GMT
finance.yahoo.com - November 8 at 4:51 PM
DaVita (DVA) Q3 Earnings Miss & Revenues Beat, '17 View DullDaVita (DVA) Q3 Earnings Miss & Revenues Beat, '17 View Dull
finance.yahoo.com - November 8 at 4:51 PM
The Biggest Loser: DaVitas Got a Case of the DropsiesThe Biggest Loser: DaVita's Got a Case of the Dropsies
finance.yahoo.com - November 8 at 4:51 PM
DaVita HealthCare Partners Inc. Profit Declines 21% In Q3 - NasdaqDaVita HealthCare Partners Inc. Profit Declines 21% In Q3 - Nasdaq
www.nasdaq.com - November 8 at 3:02 AM
DaVita Inc. to Host Earnings CallDaVita Inc. to Host Earnings Call
finance.yahoo.com - November 8 at 3:02 AM
DaVita Inc. 3rd Quarter 2017 ResultsDaVita Inc. 3rd Quarter 2017 Results
finance.yahoo.com - November 8 at 3:02 AM
DaVita HealthCare reports 3Q lossDaVita HealthCare reports 3Q loss
finance.yahoo.com - November 8 at 3:01 AM
Dialysis service provider DaVita posts quarterly lossDialysis service provider DaVita posts quarterly loss
finance.yahoo.com - November 8 at 3:01 AM
DaVita looks at divesting managed-care businesses after another poor quarterDaVita looks at divesting managed-care businesses after another poor quarter
finance.yahoo.com - November 8 at 3:01 AM
After Hours: Snap Sinks, DaVita Drops, Fossil FlopsAfter Hours: Snap Sinks, DaVita Drops, Fossil Flops
finance.yahoo.com - November 8 at 3:01 AM
DaVita HealthCare Partners Inc. (DVA) Announces  Earnings ResultsDaVita HealthCare Partners Inc. (DVA) Announces Earnings Results
www.americanbankingnews.com - November 7 at 6:54 PM
Whats in the Cards for DaVita (DVA) Stock in Q3 Earnings?What's in the Cards for DaVita (DVA) Stock in Q3 Earnings?
www.nasdaq.com - November 6 at 7:33 PM
What's in the Cards for DaVita (DVA) Stock in Q3 Earnings?What's in the Cards for DaVita (DVA) Stock in Q3 Earnings?
finance.yahoo.com - November 6 at 7:33 PM
Recent Analysis Shows OncoSec Medical, Synchrony, DaVita, Capital One, TransEnterix, and Hess Market Influences – Renewed Outlook, Key Drivers of GrowthRecent Analysis Shows OncoSec Medical, Synchrony, DaVita, Capital One, TransEnterix, and Hess Market Influences – Renewed Outlook, Key Drivers of Growth
finance.yahoo.com - November 3 at 1:26 PM
DaVita Joins Patients in Urging Congress to Pass the Bipartisan Dialysis PATIENTS Demonstration ActDaVita Joins Patients in Urging Congress to Pass the Bipartisan Dialysis PATIENTS Demonstration Act
finance.yahoo.com - November 3 at 1:26 PM
DaVita Boosts Efforts to Educate During National Diabetes MonthDaVita Boosts Efforts to Educate During National Diabetes Month
finance.yahoo.com - November 2 at 7:11 PM
The Everett Clinic Plays a Leading Role in Addressing Opioid EpidemicThe Everett Clinic Plays a Leading Role in Addressing Opioid Epidemic
finance.yahoo.com - October 31 at 7:15 PM
Integrated Care Improves Dialysis Patient Clinical OutcomesIntegrated Care Improves Dialysis Patient Clinical Outcomes
finance.yahoo.com - October 31 at 7:15 PM
DaVita Clinical Research Results Featured at American Society of Nephrology Kidney Week 2017DaVita Clinical Research Results Featured at American Society of Nephrology Kidney Week 2017
finance.yahoo.com - October 31 at 6:21 AM
DaVita HealthCare Partners Inc. (DVA) Scheduled to Post Quarterly Earnings on TuesdayDaVita HealthCare Partners Inc. (DVA) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 31 at 1:44 AM
CVS in talks to buy Aetna: RPTSCVS in talks to buy Aetna: RPTS
finance.yahoo.com - October 29 at 5:21 PM
DaVita CEO Thiry to chair Colorado effort to reform redistrictingDaVita CEO Thiry to chair Colorado effort to reform redistricting
finance.yahoo.com - October 26 at 1:44 PM
Financial Survey: DaVita HealthCare Partners (DVA) & The CompetitionFinancial Survey: DaVita HealthCare Partners (DVA) & The Competition
www.americanbankingnews.com - October 24 at 4:38 PM
DaVita HealthCare Partners Inc. (DVA) Stock Rating Upgraded by Wolfe ResearchDaVita HealthCare Partners Inc. (DVA) Stock Rating Upgraded by Wolfe Research
www.americanbankingnews.com - October 23 at 1:08 PM
Critical Analysis: DaVita HealthCare Partners (DVA) vs. Streamline Health Solutions (STRM)Critical Analysis: DaVita HealthCare Partners (DVA) vs. Streamline Health Solutions (STRM)
www.americanbankingnews.com - October 22 at 4:28 AM
DaVita, Inc. breached its 50 day moving average in a Bullish Manner : DVA-US : October 20, 2017DaVita, Inc. breached its 50 day moving average in a Bullish Manner : DVA-US : October 20, 2017
finance.yahoo.com - October 20 at 7:32 PM
 Analysts Anticipate DaVita HealthCare Partners Inc. (DVA) to Post $0.94 Earnings Per Share Analysts Anticipate DaVita HealthCare Partners Inc. (DVA) to Post $0.94 Earnings Per Share
www.americanbankingnews.com - October 20 at 10:34 AM
DaVita HealthCare Partners Inc. (DVA) Receives Average Recommendation of "Hold" from AnalystsDaVita HealthCare Partners Inc. (DVA) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - October 19 at 4:32 PM
Critical Survey: DaVita HealthCare Partners (DVA) versus Its PeersCritical Survey: DaVita HealthCare Partners (DVA) versus Its Peers
www.americanbankingnews.com - October 19 at 9:07 AM
DaVita Healthcare Partners: S&P 500’s Top Gainer on October 16DaVita Healthcare Partners: S&P 500’s Top Gainer on October 16
finance.yahoo.com - October 18 at 3:17 PM
DaVita Medical Group Provides Important Tips and Considerations for Medicare BeneficiariesDaVita Medical Group Provides Important Tips and Considerations for Medicare Beneficiaries
finance.yahoo.com - October 17 at 6:49 PM
DaVita Provides Additional Information Regarding Patients Receiving Charitable Premium AssistanceDaVita Provides Additional Information Regarding Patients Receiving Charitable Premium Assistance
finance.yahoo.com - October 16 at 6:46 PM
DaVita Inc. Schedules 3rd Quarter 2017 Investor Conference CallDaVita Inc. Schedules 3rd Quarter 2017 Investor Conference Call
finance.yahoo.com - October 16 at 6:46 PM
DaVita estimates charitable assistance loss would total up to $250MDaVita estimates charitable assistance loss would total up to $250M
finance.yahoo.com - October 16 at 6:46 PM

Social Media

Financials

Chart

DaVita HealthCare Partners (NYSE DVA) Chart for Saturday, November, 25, 2017
Loading chart…

This page was last updated on 11/25/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.